These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 19456988

  • 1. Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma.
    May M, Brookman-Amissah S, Kendel F, Knoll N, Roigas J, Hoschke B, Miller K, Gilfrich C, Pflanz S, Gralla O.
    Int J Urol; 2009 Jul; 16(7):616-21. PubMed ID: 19456988
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C, Song C, Hong JH, Kim CS, Ahn H.
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [Abstract] [Full Text] [Related]

  • 3. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J, León Ramírez D, López García S, Fernández Vázquez P, Benavente Delgado J, Ojea Calvo A.
    Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
    [Abstract] [Full Text] [Related]

  • 4. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
    Brookman-Amissah S, Kendel F, Spivak I, Pflanz S, Roigas J, Klotz T, May M.
    BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
    [Abstract] [Full Text] [Related]

  • 5. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R, Hutterer G, Chromecki T, Imamovic A, Kampel-Kettner K, Rehak P, Langner C, Pummer K.
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [Abstract] [Full Text] [Related]

  • 6. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA, Crippa A, Nesrallah L, Gonçalves PD, Leite KR, Srougi M.
    J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [Abstract] [Full Text] [Related]

  • 7. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S, Brookman-Amissah S, Roigas J, Kendel F, Hoschke B, May M.
    Scand J Urol Nephrol; 2008 Aug; 42(6):507-13. PubMed ID: 19031267
    [Abstract] [Full Text] [Related]

  • 8. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L, Patard JJ, Chiodini P, Schips L, Ficarra V, Tostain J, de La Taille A, Altieri V, Lobel B, Zigeuner RE, Artibani W, Guillé F, Abbou CC, Salzano L, Gallo C.
    Cancer; 2005 Oct 01; 104(7):1362-71. PubMed ID: 16116599
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B, Patard JJ, Méjean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valéri A, Meyer N, Jacqmin D, Lang H.
    Eur Urol; 2009 Feb 01; 55(2):452-9. PubMed ID: 18692951
    [Abstract] [Full Text] [Related]

  • 10. External validation of an international multicenter study to predict survival in Korean patients with pT2N0M0 renal cell carcinoma.
    Ku JH, Moon KC, Kwak C, Kim HH.
    Urology; 2009 Aug 01; 74(2):359-63. PubMed ID: 19501879
    [Abstract] [Full Text] [Related]

  • 11. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF, Arap MA, Antunes AA, Cury J, Leite KR, Srougi M.
    J Urol; 2007 May 01; 177(5):1687-91. PubMed ID: 17437783
    [Abstract] [Full Text] [Related]

  • 12. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y, Saito K, Iimura Y, Sakai Y, Koga F, Kawakami S, Kumagai J, Kihara K.
    J Urol; 2008 Oct 01; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma.
    Tan MH, Kanesvaran R, Li H, Tan HL, Tan PH, Wong CF, Chia KS, Teh BT, Yuen J, Chong TW.
    Urology; 2010 Jun 01; 75(6):1365-1370; 1370.e1-3. PubMed ID: 20022084
    [Abstract] [Full Text] [Related]

  • 14. Outcomes following partial nephrectomy by tumor size.
    Crispen PL, Boorjian SA, Lohse CM, Sebo TS, Cheville JC, Blute ML, Leibovich BC.
    J Urol; 2008 Nov 01; 180(5):1912-7. PubMed ID: 18801543
    [Abstract] [Full Text] [Related]

  • 15. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC, Han KR, Bui MH, Pantuck AJ, Dorey FJ, Figlin RA, Belldegrun A.
    Cancer; 2003 Dec 15; 98(12):2566-75. PubMed ID: 14669275
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up.
    Lang H, Lindner V, Letourneux H, Martin M, Saussine C, Jacqmin D.
    Eur Urol; 2004 Sep 15; 46(3):331-5. PubMed ID: 15306103
    [Abstract] [Full Text] [Related]

  • 17. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM.
    J Urol; 2001 Jul 15; 166(1):68-72. PubMed ID: 11435825
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma.
    Steiner T, Knels R, Schubert J.
    Eur Urol; 2004 Sep 15; 46(3):327-30. PubMed ID: 15306102
    [Abstract] [Full Text] [Related]

  • 19. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R, Roscigno M, Freschi M, Strada E, Petralia G, Pasta A, Matloob R, Sozzi F, Da Pozzo L, Colombo R, Guazzoni G, Doglioni C, Montorsi F, Rigatti P.
    J Urol; 2009 May 15; 181(5):2027-32. PubMed ID: 19286201
    [Abstract] [Full Text] [Related]

  • 20. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T, Sakai I, Hara I, Eto H, Miyake H.
    Int J Urol; 2004 May 15; 11(5):264-8. PubMed ID: 15147540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.